louisiana glp-1 class action drugs more likely to be prescribed for women than men Novo Nordisk is suing Eli

However, dedicated kidney outcome trials for GLP-1 receptor agonists remain limited, and further long-term studies are needed to better define their role in CKD management

Neri S, Pistone G, Saraceno B, et al

Tablets & over-the-counter supplements available

These solutions include improved clinical assessment protocols, enhanced provider education, standardized diagnostic pathways, and selective use of advanced diagnostic technologies

The challenge with that is that when you prescribe something off-label, in the case of GLP-1s in particular health insurers arent covering it

Medications were unchanged for at least 4 months before and during the study